Resmed (Germany) Analysis
| RMEA Stock | EUR 20.00 0.20 0.99% |
Resmed Inc DRC is undervalued with Real Value of 20.89 and Hype Value of 20.0. The main objective of Resmed stock analysis is to determine its intrinsic value, which is an estimate of what Resmed Inc DRC is worth, separate from its market price. There are two main types of Resmed's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Resmed's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Resmed's stock to identify patterns and trends that may indicate its future price movements.
The Resmed stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Resmed's ongoing operational relationships across important fundamental and technical indicators.
Resmed |
Resmed Stock Analysis Notes
The company has Price/Earnings To Growth (PEG) ratio of 1.73. Resmed Inc DRC last dividend was issued on the 8th of February 2023. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. RESMED CUFS10 is traded on Frankfurt Stock Exchange in Germany. To find out more about Resmed Inc DRC contact BE MBA at 858 836 5000 or learn more at https://www.resmed.com.Resmed Inc DRC Investment Alerts
| Resmed Inc DRC generated a negative expected return over the last 90 days | |
| The company has €765.33 Million in debt which may indicate that it relies heavily on debt financing |
Resmed Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 29.64 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Resmed's market, we take the total number of its shares issued and multiply it by Resmed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Resmed Profitablity
Resmed's profitability indicators refer to fundamental financial ratios that showcase Resmed's ability to generate income relative to its revenue or operating costs. If, let's say, Resmed is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Resmed's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Resmed's profitability requires more research than a typical breakdown of Resmed's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.22 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.28 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.28. Technical Drivers
As of the 23rd of March, Resmed holds the Coefficient Of Variation of (1,136), risk adjusted performance of (0.07), and Variance of 3.49. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Resmed, as well as the relationship between them. Please check Resmed Inc DRC coefficient of variation, variance, and the relationship between the mean deviation and standard deviation to decide if Resmed Inc DRC is priced some-what accurately, providing market reflects its current price of 20.0 per share.Resmed Inc DRC Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Resmed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Resmed Inc DRC. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Resmed Outstanding Bonds
Resmed issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Resmed Inc DRC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Resmed bonds can be classified according to their maturity, which is the date when Resmed Inc DRC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Resmed Predictive Daily Indicators
Resmed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Resmed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 20.0 | |||
| Day Typical Price | 20.0 | |||
| Price Action Indicator | (0.10) | |||
| Period Momentum Indicator | (0.20) | |||
| Relative Strength Index | 42.01 |
Resmed Forecast Models
Resmed's time-series forecasting models are one of many Resmed's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Resmed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Resmed Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Resmed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Resmed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Resmed. By using and applying Resmed Stock analysis, traders can create a robust methodology for identifying Resmed entry and exit points for their positions.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. RESMED CUFS10 is traded on Frankfurt Stock Exchange in Germany.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Resmed to your portfolios without increasing risk or reducing expected return.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Complementary Tools for Resmed Stock analysis
When running Resmed's price analysis, check to measure Resmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Resmed is operating at the current time. Most of Resmed's value examination focuses on studying past and present price action to predict the probability of Resmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Resmed's price. Additionally, you may evaluate how the addition of Resmed to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| CEOs Directory Screen CEOs from public companies around the world |